Belmont, MA, United States of America

Yulin Peng



Average Co-Inventor Count = 8.1

ph-index = 3

Forward Citations = 51(Granted Patents)


Location History:

  • Belmont, MA (US) (2005 - 2007)
  • Waltham, MA (US) (2007)

Company Filing History:


Years Active: 2005-2007

Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: Yulin Peng: Innovator in Antibacterial Compounds

Introduction

Yulin Peng is a notable inventor based in Belmont, MA (US), recognized for his contributions to the field of pharmaceuticals. He holds a total of five patents, focusing primarily on antibacterial compounds that have significant implications for medical treatments.

Latest Patents

Among his latest patents, Yulin Peng has developed compounds such as the 9a, 11-3C-bicyclic 9a-azalide derivatives. This invention discloses compounds of formula I, or pharmaceutically acceptable salts, esters, or prodrugs thereof, which exhibit antibacterial properties. The invention further relates to pharmaceutical compositions comprising these compounds for administration to subjects in need of antibiotic treatment. Additionally, it includes methods for treating bacterial infections by administering these pharmaceutical compositions. Another significant patent is the 6-11 bicyclic ketolide derivatives, which similarly disclose compounds of formula I with antibacterial properties and related pharmaceutical applications.

Career Highlights

Yulin Peng is currently employed at Enanta Pharmaceuticals, Inc., where he continues to innovate in the field of antibacterial treatments. His work has contributed to advancements in pharmaceutical compositions that are crucial for combating bacterial infections.

Collaborations

Yulin collaborates with talented coworkers, including Yat Sun Or and Ly Tam Phan, who contribute to the research and development of new pharmaceutical solutions.

Conclusion

Yulin Peng's innovative work in developing antibacterial compounds showcases his commitment to improving medical treatments. His patents reflect significant advancements in the pharmaceutical industry, emphasizing the importance of research in combating bacterial infections.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…